Lankelma J - Search Results

1

Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences.

Broxterman HJ, Lankelma J, Hoekman K. Broxterman HJ, et al. Among authors: lankelma j. Drug Resist Updat. 2003 Jun;6(3):111-27. doi: 10.1016/s1368-7646(03)00026-8. Drug Resist Updat. 2003. PMID: 12860459 Review.

2

Multidrug resistance proteins and other drug transport-related resistance to natural product agents.

Broxterman HJ, Giaccone G, Lankelma J. Broxterman HJ, et al. Among authors: lankelma j. Curr Opin Oncol. 1995 Nov;7(6):532-40. doi: 10.1097/00001622-199511000-00011. Curr Opin Oncol. 1995. PMID: 8547402 Review.

3

A doxorubicin-CNGRC-peptide conjugate with prodrug properties.

van Hensbergen Y, Broxterman HJ, Elderkamp YW, Lankelma J, Beers JC, Heijn M, Boven E, Hoekman K, Pinedo HM. van Hensbergen Y, et al. Among authors: lankelma j. Biochem Pharmacol. 2002 Mar 1;63(5):897-908. doi: 10.1016/s0006-2952(01)00928-5. Biochem Pharmacol. 2002. PMID: 11911842

4

Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.

Versantvoort CH, Broxterman HJ, Pinedo HM, de Vries EG, Feller N, Kuiper CM, Lankelma J. Versantvoort CH, et al. Among authors: lankelma j. Cancer Res. 1992 Jan 1;52(1):17-23. Cancer Res. 1992. PMID: 1309222

5

Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.

Versantvoort CH, Broxterman HJ, Feller N, Dekker H, Kuiper CM, Lankelma J. Versantvoort CH, et al. Among authors: lankelma j. Int J Cancer. 1992 Apr 1;50(6):906-11. doi: 10.1002/ijc.2910500615. Int J Cancer. 1992. PMID: 1348241

6

P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.

Spoelstra EC, Dekker H, Schuurhuis GJ, Broxterman HJ, Lankelma J. Spoelstra EC, et al. Among authors: lankelma j. Biochem Pharmacol. 1991 Feb 1;41(3):349-59. doi: 10.1016/0006-2952(91)90531-9. Biochem Pharmacol. 1991. PMID: 1671638

7

Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule.

van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJ, Pinedo HM, et al. van der Valk P, et al. Among authors: lankelma j. Ann Oncol. 1990;1(1):56-64. Ann Oncol. 1990. PMID: 1706611 Free article.

8

Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.

Lankelma J, Spoelstra EC, Dekker H, Broxterman HJ. Lankelma J, et al. Biochim Biophys Acta. 1990 Dec 10;1055(3):217-22. doi: 10.1016/0167-4889(90)90035-c. Biochim Biophys Acta. 1990. PMID: 1979920

9

The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.

Schuurhuis GJ, Broxterman HJ, Pinedo HM, van Heijningen TH, van Kalken CK, Vermorken JB, Spoelstra EC, Lankelma J. Schuurhuis GJ, et al. Among authors: lankelma j. Br J Cancer. 1990 Oct;62(4):591-4. doi: 10.1038/bjc.1990.335. Br J Cancer. 1990. PMID: 2223576 Free PMC article. No abstract available.

10

Differential sensitivity of multi-drug-resistant and -sensitive cells to resistance-modifying agents and the relation with reversal of anthracycline resistance.

Schuurhuis GJ, Pinedo HM, Broxterman HJ, van Kalken CK, Kuiper CM, Lankelma J. Schuurhuis GJ, et al. Among authors: lankelma j. Int J Cancer. 1990 Aug 15;46(2):330-6. doi: 10.1002/ijc.2910460232. Int J Cancer. 1990. PMID: 2384279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters